Literature DB >> 28778682

Performance of the PSI and CURB-65 scoring systems in predicting 30-day mortality in healthcare-associated pneumonia.

Efrén Murillo-Zamora1, Alfredo Medina-González2, Liliana Zamora-Pérez3, Andrés Vázquez-Yáñez4, José Guzmán-Esquivel5, Benjamín Trujillo-Hernández6.   

Abstract

INTRODUCTION: Healthcare-associated pneumonia (HCAP) is the leading cause of infection in a hospital setting and is associated with a high mortality rate. This study aimed to evaluate the performance of the pneumonia severity index (PSI) and confusion, urea, respiratory rate, blood pressure, age≥65 (CURB-65) systems in predicting 30-day mortality in HCAP in adult patients. PATIENTS AND METHODS: A cross-sectional study took place and data from 109 non-immunocompromised individuals aged>18 years were analyzed. The clinical diagnosis of HCAP included the presence of radiographic infiltrates in patients≥48hours after hospital admission. The PSI and CURB-65 scores were calculated and performance measures were estimated. Summary statistics were used to describe the study sample. The PSI and CURB-65 scores were calculated based on 20 and 5 criteria, respectively, and the performance indicators of the screening tools were estimated.
RESULTS: The overall 30-day mortality was 59.6%. At every given threshold, PSI sensitivity was higher, but showed a lower specificity than the CURB-65, and the highest Youden index (0.392) was observed at cut-off V in the PSI. The area under the ROC curve was 0.737 (95% CI: 0.646-0.827) and 0.698 (95% CI: 0.600-0.797) using the PSI and CURB-65 systems, respectively (P=.323).
CONCLUSION: Our findings suggest that the performance of the PSI and CURB-65 is reasonable for predicting 30-day mortality in adult HCAP patients and may be used in healthcare settings.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Asociación a la asistencia sanitaria; Evaluation index; Healthcare-associated; Mortalidad; Mortality; Neumonía; Pneumonia; Índice de evaluación

Mesh:

Year:  2017        PMID: 28778682     DOI: 10.1016/j.medcli.2017.06.044

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  10 in total

1.  CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study.

Authors:  J Carriel; R Muñoz-Jaramillo; O Bolaños-Ladinez; F Heredia-Villacreses; J Menéndez-Sanchón; J Martin-Delgado
Journal:  Rev Clin Esp (Barc)       Date:  2021-04-30

2.  [CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study].

Authors:  J Carriel; R Muñoz-Jaramillo; O Bolaños-Ladinez; F Heredia-Villacreses; J Menéndez-Sanchón; J Martin-Delgado
Journal:  Rev Clin Esp       Date:  2020-10-22       Impact factor: 1.556

3.  Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.

Authors:  Jingyuan Liu; Yao Liu; Pan Xiang; Lin Pu; Haofeng Xiong; Chuansheng Li; Ming Zhang; Jianbo Tan; Yanli Xu; Rui Song; Meihua Song; Lin Wang; Wei Zhang; Bing Han; Li Yang; Xiaojing Wang; Guiqin Zhou; Ting Zhang; Ben Li; Yanbin Wang; Zhihai Chen; Xianbo Wang
Journal:  J Transl Med       Date:  2020-05-20       Impact factor: 5.531

4.  Pneumonia scoring systems for severe COVID-19: which one is better.

Authors:  PengFei Cheng; Hao Wu; JunZhe Yang; XiaoYang Song; MengDa Xu; BiXi Li; JunJun Zhang; MingZhe Qin; Cheng Zhou; Xiang Zhou
Journal:  Virol J       Date:  2021-02-10       Impact factor: 4.099

5.  Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China.

Authors:  Shui-Sheng Zhang; Li Dong; Gao-Ming Wang; Yuan Tian; Xiao-Fang Ye; Yue Zhao; Zheng-Yin Liu; Jia-Yu Zhai; Zhi-Ling Zhao; Jun-Hong Wang; Hui-Min Zhang; Xiao-Long Li; Chang-Xin Wu; Cai-Ting Yang; Li-Juan Yang; Hai-Xia Du; Hui Wang; Qing-Gang Ge; Dian-Rong Xiu; Ning Shen
Journal:  World J Gastroenterol       Date:  2021-03-07       Impact factor: 5.742

6.  Risk factors for 3-month mortality in bedridden patients with hospital-acquired pneumonia: A multicentre prospective study.

Authors:  Jing Jiao; Zhen Li; Xinjuan Wu; Jing Cao; Ge Liu; Ying Liu; Fangfang Li; Chen Zhu; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xia Wan
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

7.  Prevalence of clinical and radiologic features in methanol-poisoned patients with and without COVID-19 infection.

Authors:  Nasim Zamani; Farzad Gheshlaghi; Maryam Haghighi-Morad; Hooman Bahrami-Motlagh; Ilad Alavi Darazam; Seyed Kaveh Hadeiy; Rebecca McDonald; Hossein Hassanian-Moghaddam
Journal:  Acute Med Surg       Date:  2021-12-06

8.  Comparison of Different Scoring Systems for Prediction of Mortality and ICU Admission in Elderly CAP Population.

Authors:  Chunxin Lv; Yue Chen; Wen Shi; Teng Pan; Jinhai Deng; Jiayi Xu
Journal:  Clin Interv Aging       Date:  2021-10-28       Impact factor: 4.458

9.  Clinical characteristics and prognostic factors of COVID-19 patients progression to severe: a retrospective, observational study.

Authors:  Yunfei Liao; Yong Feng; Bo Wang; Hanyu Wang; Jinsha Huang; Yaxin Wu; Ziling Wu; Xiao Chen; Chao Yang; Xinqiao Fu; Hui Sun
Journal:  Aging (Albany NY)       Date:  2020-10-14       Impact factor: 5.682

10.  Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study.

Authors:  Jun Hirai; Takeshi Kinjo; Tomomi Koga; Shusaku Haranaga; Eiji Motonaga; Jiro Fujita
Journal:  BMC Infect Dis       Date:  2020-11-10       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.